Precipio, Inc. (NASDAQ:PRPO – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $6.64 and traded as low as $6.06. Precipio shares last traded at $6.15, with a volume of 3,618 shares trading hands.
Precipio Price Performance
The firm has a 50 day simple moving average of $6.41 and a 200-day simple moving average of $6.64. The company has a quick ratio of 1.05, a current ratio of 1.17 and a debt-to-equity ratio of 0.01. The company has a market cap of $8.79 million, a PE ratio of -1.35 and a beta of 1.61.
Precipio Company Profile
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests.
Read More
- Five stocks we like better than Precipio
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Stock Dividend Cuts Happen Are You Ready?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
